FindTrial
Sign In

Envarsus Oral Product

DRUG2 trials

Sponsors

Imperial College Healthcare NHS Trust, University of Alberta

Conditions

AllosensitizationCardiovascular DiseasesImmunosuppressant Adverse ReactionImmunosuppressionKidney Transplant FailureLiver Transplant; ComplicationsMetabolic SyndromeRenal Insufficiency

Phase 4

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation
TerminatedNCT03689075
Imperial College Healthcare NHS TrustAllosensitization, Immunosuppression, Kidney Transplant Failure
Start: 2018-11-01End: 2025-02-25Updated: 2025-04-13
Extended-Release Tacrolimus Following Liver Transplantation
RecruitingNCT05242315
University of AlbertaCardiovascular Diseases, Immunosuppressant Adverse Reaction, Liver Transplant; Complications +2
Start: 2022-05-15End: 2034-02-15Target: 94Updated: 2026-09-15